Skullcapflavone I has a potent anti‐pancreatic cancer activity by targeting miR‐23a

Baicalein has been widely studied and showed a potent activity against pancreatic cancer in both in vivo and in vitro studies. Little is known regarding the effects of Skullcapflavone I (SFI), despite they have similar structures. So, this study was to explore the function of SFI on human pancreatic cancer. Panc‐1 cells were transfected with miR‐23a precursor, miR‐23a inhibitor or the negative controls, and subsequently treated by SFI. Cell...